Updates

What’s New… November 13, 2024 meeting

Carboxymethylcellulose 0.5% ophthalmic drops and Dequalinium (Dequadin) throat lozenges were added to formulary due to Health Pro contract changes.

Potassium Phosphate 15 mmol/250 mL D5W and 30 mmol/500 mL D5W have been added to the formulary at the Regional Centers which should eliminate after hour requests for compounding.

After a comprehensive review of SH-SS inhalers, the following were added to the formulary: Combivent Respimat, Spiriva Respimat. Advair MDI will be removed and replaced by Wixela Diskus to decrease the greenhouse gases in the environment from the propellant hydrofluoroalkane (HFA). More info is shared on the briefing note for the updated Automatic Substitution Medication List in Acute Care.

The Acute Care Formulary Review policy was created with a Process for Handling Non-Formulary Medication Orders.

The Emergency Department Adult Intravenous Iron Administration Standard Orders was revised to reflect the name change of Monoferric from iron isomaltoside to ferric derisomaltose. Labs were also changed from Fe, TIBC to TSTAT (Percent transferrin saturation; report includes iron & TIBC).

Medication Order Writing and Processing policy was updated with more exclusive wording for texting orders using provincial or SH-SS approved secure communication for communication. It also refers to the regional Secure Messaging for Patient Care policy.

FORMULARY

• Carboxymethcellulose 1% to 0.5% ophthalmic
• Lozenges Bradasol to Dequadin
• Potassium Phosphate 15/250 & 30/500 (mmol /mL D5W)
• Meperidine inj restrictions
• Combivent Respimat
• Too many to list, see memo
  POLICIES
• AutoSub list Acute Care
  a. Spiriva caps to Respimat
  b. Advair MDI to Diskus
  c. Salbutamol preferred brand Teva
• Acute Care Formulary Review
• Adult Intravenous Iron Administration in ED Standard Orders updated
• Medication Order Writing and Processing
• Secure Messaging for Patient Care

MONOGRAPHS

• Too many to list, see memo

POLICIES

• AutoSub list Acute Care
  • Spiriva caps to Respimat
  • Advair MDI to Diskus
  • Salbutamol preferred brand Teva
• Acute Care Formulary Review
• Adult Intravenous Iron Administration in ED Standard Orders updated
• Medication Order Writing and Processing
• Secure Messaging for Patient Care

For more info. go to the GENERAL shared folder to review the completed Pharmacy & Therapeutics minutes

Drug Monographs

Updates

What’s New… Sept 11, 2024 meeting

• rifAXImin 550 mg tab
• caspofungin 50 & 70 mg IV
• DAPTOmycin 500 mg IV
  MONOGRAPHS
• LTC Nirmatrelvir + Ritonavir (Paxlovid) for Oral Treatment of COVID19 in Adults Standard Orders
• Emergency Department Adult Clinical Decision Tool (Nurse may implement) Standard Orders

---

• rifAXImin PO has been added to the formulary with restrictions as per Part 3 EDS criteria for reducing the risk of overt encephalopathy recurrence
• Caspofungin IV has been added to the formulary with restrictions; it requires a consultation with Adult ID Consult Service for invasive candidiasis
• DAPTOmycin IV has also been added to the formulary with restrictions; it also requires a consultation with the Adult Infectious Diseases Service for indications listed on the formulary updated on the StaffNET
• LTC Nirmatrelvir + Ritonavir (Paxlovid) for Oral Treatment of COVID-19 in Adults Standard Orders has been updated with changes due to the inclusion of off-label Paxlovid dosing for eGFR less than 30 mL/min in the updated Shared Health clinical guidance
• Emergency Department Adult Clinical Decision Tool (Nurse may Implement) Standard Orders is a revised standard order where users should apply CTAS and clinical judgement following the Clinical Decision Tool policy CLI.5110.PL.002. In PCH, we will follow the Manitoba Biosimilar Guideline Manitoba Biosimilars Initiative | Health | Province of Manitoba (gov.mb.ca). A new prescription from the prescriber is required for the products listed in the guideline
• Obstetric pre-printed MARs were recently updated to reflect the layout of the BDM cMARs.

For more info. go to the GENERAL shared folder to review the completed Pharmacy & Therapeutics minutes

Drug Monographs